The effect of trastuzumab-based therapy on overall survival in small, node-negative HER2-positive breast cancer: To treat or not to treat?

被引：0
|
作者：
van Ramshorst, M. S.
van der Heijden-van der Loo, M.
Dackus, G. M. H. E.
Linn, S. C.
Sonke, G. S.
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Comprehens Canc Org, Utrecht, Netherlands
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-S6-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S6-06
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The effect of trastuzumab-based therapy on overall survival in small, node-negative HER2-positive breast cancer: To treat or not to treat?
    van Ramshorst, M. S.
    van der Heijden-van der Loo, M.
    Dackus, G. M. H. E.
    Linn, S. C.
    Sonke, G. S.
    CANCER RESEARCH, 2016, 76
  • [2] The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    van Ramshorst, Mette S.
    van der Heiden-van der Loo, Margriet
    Dackus, Gwen M. H. E.
    Linn, Sabine C.
    Sonke, Gabe S.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (02) : 361 - 371
  • [3] The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    Mette S. van Ramshorst
    Margriet van der Heiden-van der Loo
    Gwen M. H. E. Dackus
    Sabine C. Linn
    Gabe S. Sonke
    Breast Cancer Research and Treatment, 2016, 158 : 361 - 371
  • [4] Erratum to: The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    Mette S. van Ramshorst
    Margriet van der Heiden-van der Loo
    Gwen M. H. E. Dackus
    Sabine C. Linn
    Gabe S. Sonke
    Breast Cancer Research and Treatment, 2016, 159 : 393 - 393
  • [5] The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer (vol 158, pg 361, 2016)
    van Ramshorst, Mette S.
    van der Heiden-van der Loo, Margriet
    Dackus, Gwen M. H. E.
    Linn, Sabine C.
    Sonke, Gabe S.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (02) : 393 - 393
  • [6] Trastuzumab and Chemotherapy May Be Appropriate for Small, Node-Negative, HER2-Positive Breast Cancer
    Morris, Patrick G.
    McArthur, Heather L.
    ONCOLOGIST, 2012, 17 (10): : E33 - E33
  • [7] Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
    Tolaney, Sara M.
    Barry, William T.
    Dang, Chau T.
    Yardley, Denise A.
    Moy, Beverly
    Marcom, P. Kelly
    Albain, Kathy S.
    Rugo, Hope S.
    Ellis, Matthew
    Shapira, Iuliana
    Wolff, Antonio C.
    Carey, Lisa A.
    Overmoyer, Beth A.
    Partridge, Ann H.
    Guo, Hao
    Hudis, Clifford A.
    Krop, Ian E.
    Burstein, Harold J.
    Winer, Eric P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (02): : 134 - 141
  • [8] Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer
    Cochereau, D.
    Cottu, P.
    ONCOLOGIE, 2015, 17 (04) : 194 - 196
  • [9] Trastuzumab and Chemotherapy May Be Appropriate for Small, Node-Negative, HER2-Positive Breast Cancer In Reply
    Connolly, Roisin M.
    Bardia, Aditya
    ONCOLOGIST, 2012, 17 (10): : E34 - E34
  • [10] Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer
    McArthur, Heather L.
    Mahoney, Kathleen M.
    Morris, Patrick G.
    Patil, Sujata
    Jacks, Lindsay M.
    Howard, Jane
    Norton, Larry
    Hudis, Clifford A.
    CANCER, 2011, 117 (24) : 5461 - 5468
12345